Cargando…

Interpretation of the diagnosis and treatment protocol for COVID‐19 (Trial Version 9)

Detalles Bibliográficos
Autor principal:	Rongmeng, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349576/ http://dx.doi.org/10.1002/hcs2.3

Ejemplares similares

Diagnosis and treatment protocol for COVID‐19 patients (Trial Version 9)
Publicado: (2022)

Translation: Diagnosis and Treatment Protocol for COVID-19 (Trial Version 9)
Publicado: (2022)

Interpretations of “Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)”
por: Zhao, Jing-Ya, et al.
Publicado: (2020)

Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Version)
Publicado: (2022)

Translation: Diagnosis and Treatment Protocol for COVID-19 (Revised Trial Version 8)
Publicado: (2022)

Interpretations and comments for expert consensus on the diagnosis and treatment of heat stroke in China
por: Liu, Shu-Yuan, et al.
Publicado: (2020)

Inside China and COVID-19: Questions and answers
por: Jiang, Rongmeng
Publicado: (2020)

Introducing the New Versions of Chinese Diagnosis and Treatment Protocol for COVID-19
Publicado: (2022)

Teaching Deliberation and Restraint in Interpreting a Tempest of COVID-19 “Information”
por: Mazer, Adrien J., et al.
Publicado: (2021)

Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)
Publicado: (2020)

Interpreting the odds
por: Fisher, Malcolm
Publicado: (1998)

Prediction or interpretability?
por: Nembrini, Stefano
Publicado: (2019)

Approaches to interpreting and choosing the best treatments in network meta-analyses
por: Mbuagbaw, L., et al.
Publicado: (2017)

Interpreting the results of patient reported outcome measures in clinical trials: The clinician's perspective
por: Schünemann, Holger J, et al.
Publicado: (2006)

Randomised Controlled Trials in Diabetes Research: A Pathway to Interpreting Published Results
por: Battelino, Tadej, et al.
Publicado: (2021)

Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines
por: den Heijer, Jonas M., et al.
Publicado: (2021)

Commentary: Can pathologists interpret digital images as well as they interpret microscope slides?
por: Bauer, Thomas W.
Publicado: (2016)

Moderating Effects in Randomized Trials—Interpreting the P Value, Confidence Intervals, and Hazard Ratios
por: Agarwal, Rajiv, et al.
Publicado: (2022)

Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotations
por: Jørgensen, Karsten J, et al.
Publicado: (2006)

COVID-19 management: Opportunity to reassess protocols?
por: Sodhi, Jitender, et al.
Publicado: (2022)

Diagnosis of COVID-19 in children: the story evolves
por: Harwood, R., et al.
Publicado: (2020)

Why prudence is needed when interpreting articles reporting clinical trial results in mental health
por: Dal-Ré, Rafael, et al.
Publicado: (2017)

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials
por: Gallagher, Jason C., et al.
Publicado: (2023)

NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?
por: Kelleni, Mina T.
Publicado: (2021)

Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 8th Edition): Interpretation of Updated Key Points
por: Wang, Gui-Qiang, et al.
Publicado: (2021)

Psychometric Properties of the Fear of COVID-19 Scale: a Response to Mercado-Lara et al. “Validity and Reliability of the Spanish Version of Fear of COVID-19 Scale in Colombian Physicians”
por: Lin, Chung-Ying, et al.
Publicado: (2021)

Commentary: Rethinking surgical protocols in the COVID-19 era
por: Engelman, Daniel T., et al.
Publicado: (2020)

Laboratory Diagnosis of COVID-19: Current Issues and Challenges
por: Tang, Yi-Wei, et al.
Publicado: (2020)

COVID-19: underpowered randomised trials, or no randomised trials?
por: Fretheim, Atle
Publicado: (2021)

Endpoints used in phase III randomized controlled trials of treatment options for COVID-19
por: Desai, Aakash, et al.
Publicado: (2020)

Genome interpretation: Clinical correlation is recommended
por: Segal, Michael M.
Publicado: (2015)

Considerations on the clinical development of COVID-19 vaccine from trial design perspectives
por: Jiang, Zhiwei, et al.
Publicado: (2020)

Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy
por: Faria, Karina Morais, et al.
Publicado: (2020)

A commentary on “Diagnosis and treatment of coronavirus disease 2019 (COVID-19) Laboratory, PCR, and chest CT imaging findings”
por: Shuang Wu, M.M., et al.
Publicado: (2021)

Indian Version of ID-Migraine Questionnaire
por: Prakash, Sanjay, et al.
Publicado: (2023)

Interpreting success or failure of peanut oral immunotherapy
por: Cao, Shijie, et al.
Publicado: (2022)

Commentary: Ocular myasthenia gravis: Interpreting the investigations
por: Nair, Akshay Gopinathan
Publicado: (2022)

A proposed framework for the interpretation of biomonitoring data
por: Boogaard, Peter J, et al.
Publicado: (2008)

Tread Lightly Interpreting Polygenic Tests of Selection
por: Novembre, John, et al.
Publicado: (2018)

Interpretation of Results from Under‐accruing Studies
por: Kravets, Sasha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3q3ddh0u8h5v1qvln3h7b2cnhg